On Demand Webinar

Licensing Biological Materials: Crucial Considerations for Preclinical Researchers

Licensing biological material for preclinical research can be challenging and requires a clear understanding of the legal, ethical, and regulatory frameworks involved. In this webinar, we explore key considerations for ensuring that biological material is properly licensed for use in both research and commercial settings, helping you avoid potential financial and reputational damage.

This interactive session, hosted by Scientist.com, covers topics such as best practices for tracking and managing licenses, legal frameworks, and case studies on successful agreements.

Watch Now

Learn how to protect your research from potential legal risks:

• Understand the critical importance of biological material licensing in preclinical research.
• Learn best practices for managing licensing agreements.
• Gain insights into intellectual property (IP) and other contractual considerations, including patents and compliance.
• Explore real-world case studies on navigating licensing challenges in CROs and beyond.

Watch Now

About the speaker:

Jim Sullivan, Senior Director of Corporate Development & Strategy, Crown Bioscience

In his current role, Jim manages Crown Bioscience’s corporate partnerships in North America and Europe, which includes licensing in cell lines, organoid and PDX models from academic, non-profit and industry partners. His previous roles include Business Development at Crown Bioscience and other CROs, as well as Product Management and sales roles at both established as well as startup Life Science companies. Jim has an undergraduate degree in Biology from Holy Cross and an MBA from Boston College.